ArticleEvidence-based complementary and alternative medicine : eCAM2017
Anticancer Effect of
Article in Evidence-based complementary and alternative medicine : eCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 38 citations in OpenAlex.
- Novel oral delivery system using modified inulin for enhanced liver cancer therapy.Journal of food and drug analysis · 2026Article
- Cytotoxic Effects of Cnidarian Venoms: One Cancer, Two Cell Lines.Marine biotechnology (New York, N.Y.) · 2026Article
- Characterization of Novel ACE-Inhibitory Peptides fromMarine drugs · 2025Article
- Identification of New Angiotensin-Converting Enzyme Inhibitory Peptides Isolated from the Hydrolysate of the Venom ofToxins · 2024Article
- Synthetic ShK-like Peptide from the JellyfishMarine drugs · 2024Article
- Jellyfishes-Significant Marine Resources with Potential in the Wound-Healing Process: A Review.Marine drugs · 2023Review
- Chemical Compositions and Experimental and Computational Modeling of the Anticancer Effects of Cnidocyte Venoms of JellyfishMarine drugs · 2023Article
- Jellyfish as an Alternative Source of Bioactive Antiproliferative Compounds.Marine drugs · 2022Article
- Jellyfish from Fisheries By-Catches as a Sustainable Source of High-Value Compounds with Biotechnological Applications.Marine drugs · 2022Review
- Anti-Cancer Activity ofMolecules (Basel, Switzerland) · 2022Article
- Developing natural marine products for treating liver diseases.World journal of clinical cases · 2022Review
- Nomad JellyfishMolecules (Basel, Switzerland) · 2021Article
- Field Experiment Effect on Citrus Spider MiteToxins · 2021Article
- Anti-Cancer Effect of Moroccan CobraToxins · 2021Article
- Proteomic Analysis of the Venom of JellyfishesMarine drugs · 2020Article
- Biotechnological Applications of Scyphomedusae.Marine drugs · 2019Review
- Article
- Nemopilema nomurai jellyfish venom exerts an anti-metastatic effect by inhibiting Smad- and NF-κB-mediated epithelial-mesenchymal transition in HepG2 cells.Scientific reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Various kinds of animal venoms and their components have been widely studied for potential therapeutic applications. This study evaluated whether
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.